Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM. Neuropsychiatr Dis Trea. 2014;10:391–401. On page 393, Figure 1, “Maintenance period (month 6 to 24)” should be “Maintenance period (month 4 to 24)”; &...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/09ce8a88547845a3adad92e246cc5c0a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:09ce8a88547845a3adad92e246cc5c0a
record_format dspace
spelling oai:doaj.org-article:09ce8a88547845a3adad92e246cc5c0a2021-12-02T01:46:53ZEffects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]1178-2021https://doaj.org/article/09ce8a88547845a3adad92e246cc5c0a2014-10-01T00:00:00Zhttp://www.dovepress.com/corrigendum-effects-of-galantamine-in-a-2-year-randomized-placebo-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021 Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM. Neuropsychiatr Dis Trea. 2014;10:391–401. On page 393, Figure 1, “Maintenance period (month 6 to 24)” should be “Maintenance period (month 4 to 24)”; “– Gal at stable dose (at least 18 mg/day) as achieved on day 84c” should be “– Gal at stable dose (at least 16 mg/day) as achieved on day 84c”. Read the original articleHager KBaseman ASNye JSBrashear HRHan JSano MDavis BRichards HMDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2014, Iss default, Pp 1997-1998 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Hager K
Baseman AS
Nye JS
Brashear HR
Han J
Sano M
Davis B
Richards HM
Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
description Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM. Neuropsychiatr Dis Trea. 2014;10:391–401. On page 393, Figure 1, “Maintenance period (month 6 to 24)” should be “Maintenance period (month 4 to 24)”; “– Gal at stable dose (at least 18 mg/day) as achieved on day 84c” should be “– Gal at stable dose (at least 16 mg/day) as achieved on day 84c”. Read the original article
format article
author Hager K
Baseman AS
Nye JS
Brashear HR
Han J
Sano M
Davis B
Richards HM
author_facet Hager K
Baseman AS
Nye JS
Brashear HR
Han J
Sano M
Davis B
Richards HM
author_sort Hager K
title Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
title_short Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
title_full Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
title_fullStr Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
title_full_unstemmed Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
title_sort effects of galantamine in a 2-year, randomized, placebo-controlled study in alzheimer’s disease [corrigendum]
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/09ce8a88547845a3adad92e246cc5c0a
work_keys_str_mv AT hagerk effectsofgalantamineina2yearrandomizedplacebocontrolledstudyinalzheimerrsquosdiseasecorrigendum
AT basemanas effectsofgalantamineina2yearrandomizedplacebocontrolledstudyinalzheimerrsquosdiseasecorrigendum
AT nyejs effectsofgalantamineina2yearrandomizedplacebocontrolledstudyinalzheimerrsquosdiseasecorrigendum
AT brashearhr effectsofgalantamineina2yearrandomizedplacebocontrolledstudyinalzheimerrsquosdiseasecorrigendum
AT hanj effectsofgalantamineina2yearrandomizedplacebocontrolledstudyinalzheimerrsquosdiseasecorrigendum
AT sanom effectsofgalantamineina2yearrandomizedplacebocontrolledstudyinalzheimerrsquosdiseasecorrigendum
AT davisb effectsofgalantamineina2yearrandomizedplacebocontrolledstudyinalzheimerrsquosdiseasecorrigendum
AT richardshm effectsofgalantamineina2yearrandomizedplacebocontrolledstudyinalzheimerrsquosdiseasecorrigendum
_version_ 1718402880254246912

Ejemplares similares